Edition:
United Kingdom

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

54.07EUR
18 Jun 2019
Change (% chg)

€1.54 (+2.93%)
Prev Close
€52.53
Open
€52.48
Day's High
€54.42
Day's Low
€52.08
Volume
4,203,716
Avg. Vol
3,507,331
52-wk High
€99.90
52-wk Low
€52.02

Select another date:

Tue, Jun 18 2019

Photo

Bayer asks trial judge to reverse $2 billion Roundup jury verdict

Bayer AG has asked a California judge to overrule a $2 billion verdict by jurors who found the company's glyphosate-based Roundup weed killer responsible for a couple's cancer, arguing the jury decision was not supported by evidence.

Bayer asks trial judge to reverse $2 billion Roundup jury verdict

June 18 Bayer AG has asked a California judge to overrule a $2 billion verdict by jurors who found the company's glyphosate-based Roundup weed killer responsible for a couple's cancer, arguing the jury decision was not supported by evidence.

Bayer to invest $5.6 billion in weedkiller research to help reputation

FRANKFURT Germany's Bayer sought to repair its reputation on Friday after damage caused by U.S. litigation over claims its glyphosate pesticide causes cancer, saying it would invest 5 billion euros ($5.6 billion) in weedkiller research.

UPDATE 2-Bayer to invest $5.6 bln in weedkiller research to help reputation

* CEO seeks to improve image amid U.S. glyphosate lawsuits (Adds details on investment, developing countries, lobbyist)

Bayer says to invest five billion euros in new weed killers

BERLIN Bayer said it would invest 5 billion euros (£4.5 billion) in developing new weedkillers and reducing its environmental impact by 30% by 2030, as it seeks to address the fallout from U.S. class-action litigation over glyphosate.

Bayer says to invest 5 bln euros in new weed killers

BERLIN, June 14 Bayer said it would invest 5 billion euros ($5.6 billion) in developing new weedkillers and reducing its environmental impact by 30% by 2030, as it seeks to address the fallout from U.S. class-action litigation over glyphosate.

Bayer teams up with biotech firm Arvinas in deal worth up to $750 million

FRANKFURT German drugmaker Bayer has signed an alliance with Arvinas Inc to gain access to the U.S. biotech firm's experimental protein drugs and crop protection technology in a deal worth up to $750 million.

Bayer teams up with biotech firm Arvinas in deal worth up to $750 mln

FRANKFURT, June 4 German drugmaker Bayer has signed an alliance with Arvinas Inc to gain access to the U.S. biotech firm's experimental protein drugs and crop protection technology in a deal worth up to $750 million.

Australian gardener sues Bayer's Monsanto over cancer link

SYDNEY Lawyers of an Australian gardener on Tuesday said they had filed a lawsuit against Bayer AG agricultural chemicals unit Monsanto for severe harm caused by an ingredient used in its weed killer Roundup, the first such case in the country.

Australian gardener sues Bayer's Monsanto over cancer link

SYDNEY, June 4 Lawyers of an Australian gardener on Tuesday said they had filed a lawsuit against Bayer AG agricultural chemicals unit Monsanto for severe harm caused by an ingredient used in its weed killer Roundup, the first such case in the country.

Select another date: